Skip to main content

Table 1 Correlation between LATS2-AS1-001 expression and clinicopathological features of gastric cancer

From: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2

GroupsnLATS2-AS1-001 expressionP
HighLow
Gender0.646
 Male26781186 
 Female902565 
Age (year)0.220
 ≥6020259143 
 < 6015547108 
Tumor size0.167
 ≥ 525270182 
  < 51053669 
Borrmann’s types0.394
 Bor.I + II301119 
 Bor.III + IV32795230 
WHO’s histological types0.448
 Papillary adenocarcinoma633 
Tubular adenocarcinoma
  Well differentiated1028 
  Moderately differentiated802555 
  Poorly differentiated21967152 
 Signet ring cell adenocarcinoma27621 
 Mucinous adenocarcinoma15312 
Lauren’s types0.905
 Intestinal963066 
 Diffuse18055125 
 Mixed812160 
Depth of invasion0.568
 T1 + 226917 
 T3 + 433197234 
Lymph node metastasis0.282
 N0782751 
 N1–327979200 
Distant metastasis0.968
 M0345103242 
 M11239 
TNM staging0.032
 I + II1003862 
 III + IV25768189 
  1. Significance of P < 0.05 is indicated in italic